|
SMN2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.786000E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.338600E-03 |
| Normal-vs-Stage2 |
2.604600E-03 |
| Normal-vs-Stage3 |
1.187400E-04 |
| Normal-vs-Stage4 |
2.893600E-02 |
| Stage1-vs-Stage2 |
2.366600E-01 |
| Stage1-vs-Stage3 |
1.038820E-01 |
| Stage1-vs-Stage4 |
9.324000E-01 |
| Stage2-vs-Stage3 |
9.828800E-01 |
| Stage2-vs-Stage4 |
4.091200E-01 |
| Stage3-vs-Stage4 |
2.935800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.045340E-04 |
| Normal-vs-AfricanAmerican |
1.720030E-01 |
| Normal-vs-Asian |
4.384000E-02 |
| Caucasian-vs-AfricanAmerican |
3.085600E-01 |
| Caucasian-vs-Asian |
3.432600E-01 |
| AfricanAmerican-vs-Asian |
7.705600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.561490E-04 |
| Normal-vs-Female |
8.952300E-04 |
| Male-vs-Female |
2.618600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.964500E-03 |
| Normal-vs-Age(41-60Yrs) |
3.392600E-04 |
| Normal-vs-Age(61-80Yrs) |
3.975800E-03 |
| Normal-vs-Age(81-100Yrs) |
3.417600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.052200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.019800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.509000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.841000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.624600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.101000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.610830E-01 |
| Classical-VS-Follicular |
5.532000E-01 |
| Classical-VS-Other |
9.575000E-01 |
| Classical-VS-Normal |
4.264100E-03 |
| Tall-VS-Follicular |
1.343190E-01 |
| Tall-VS-Other |
4.169800E-01 |
| Tall-VS-Normal |
8.009100E-04 |
| Follicular-VS-Other |
8.949000E-01 |
| Follicular-VS-Normal |
4.015600E-02 |
| Other-VS-Normal |
2.175000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.24560000000085E-05 |
| Normal-vs-N1 |
5.677500E-02 |
| N0-vs-N1 |
3.269600E-01 |
|
|
